On the other hand, leukemias involving the BCR-ABL fusion gene, present in about 4% of children with ALL, are characterised by a high incidence of relapses, whereas leukemias involving the TEL-AML1 fusion are associated with a good prognosis [6,7]. The gene discussed is RUNX1; the disease is leukemia.